These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 36990678)

  • 41. [Benefit/risk assessment and issues related to antibiotic use of
    Wang JB
    Zhonghua Yi Xue Za Zhi; 2020 Aug; 100(30):2343-2345. PubMed ID: 32791809
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Three-Decade Failure to the Eradication of Refractory
    Moghadam MT; Chegini Z; Norouzi A; Dousari AS; Shariati A
    Curr Pharm Biotechnol; 2021; 22(7):945-959. PubMed ID: 32767919
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of health insurance coverage for
    Hiroi S; Sugano K; Tanaka S; Kawakami K
    BMJ Open; 2017 Jul; 7(7):e015855. PubMed ID: 28760790
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Helicobacter pylori drug resistance: therapy changes and challenges.
    Flores-Treviño S; Mendoza-Olazarán S; Bocanegra-Ibarias P; Maldonado-Garza HJ; Garza-González E
    Expert Rev Gastroenterol Hepatol; 2018 Aug; 12(8):819-827. PubMed ID: 29976092
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of daily telephone-based re-education before taking medicine on Helicobacter pylori eradication: A prospective single-center study from China.
    Wang CH; Liao ST; Yang J; Li CX; Yang YY; Han R; Chen DF; Lan CH
    World J Gastroenterol; 2015 Oct; 21(39):11179-84. PubMed ID: 26494972
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The use of probiotics in Helicobacter pylori eradication therapy.
    Medeiros JA; Pereira MI
    J Clin Gastroenterol; 2013 Jan; 47(1):1-5. PubMed ID: 23222208
    [No Abstract]   [Full Text] [Related]  

  • 47. Trends of second-line eradication therapy for Helicobacter pylori in Japan: a multicenter study in the Tokyo metropolitan area.
    Asaoka D; Nagahara A; Matsuhisa T; Takahashi S; Tokunaga K; Kawai T; Kawakami K; Suzuki H; Suzuki M; Nishizawa T; Kurihara N; Ito M; Sasaki H; Omata F; Mizuno S; Torii A; Ohkusa T; Mine T; Sakaki N
    Helicobacter; 2013 Dec; 18(6):468-72. PubMed ID: 23773231
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Review: clinical management of Helicobacter pylori infection in China.
    Xie C; Lu NH
    Helicobacter; 2015 Feb; 20(1):1-10. PubMed ID: 25382801
    [TBL] [Abstract][Full Text] [Related]  

  • 49. What is the most effective regimen for eradication of Helicobacter pylori in patients who have failed a first eradication attempt?
    Markova T; Schwartz K
    J Fam Pract; 2002 Jan; 51(1):14. PubMed ID: 11927054
    [No Abstract]   [Full Text] [Related]  

  • 50. Halitosis and helicobacter pylori infection: A meta-analysis.
    Dou W; Li J; Xu L; Zhu J; Hu K; Sui Z; Wang J; Xu L; Wang S; Yin G
    Medicine (Baltimore); 2016 Sep; 95(39):e4223. PubMed ID: 27684792
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Several issues on amoxicillin in
    Yang GB
    Zhonghua Yi Xue Za Zhi; 2020 Aug; 100(30):2340-2342. PubMed ID: 32791808
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis.
    Lee YC; Chiang TH; Chou CK; Tu YK; Liao WC; Wu MS; Graham DY
    Gastroenterology; 2016 May; 150(5):1113-1124.e5. PubMed ID: 26836587
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is validation of Helicobacter pylori eradication necessary?
    Niv Y
    Isr Med Assoc J; 2003 Mar; 5(3):198-200. PubMed ID: 12725143
    [No Abstract]   [Full Text] [Related]  

  • 54. [First line eradication treatment of Helicobacter pylori in 2019].
    Gressot P; Frossard JL; Grosgurin O; Marti C
    Rev Med Suisse; 2019 Oct; 15(667):1854-1858. PubMed ID: 31617972
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Time to learn from the past and prepare for the future in Helicobacter pylori eradication.
    Bang CS; Baik GH
    Korean J Intern Med; 2015 Nov; 30(6):789-91. PubMed ID: 26552453
    [No Abstract]   [Full Text] [Related]  

  • 56. [Helicobacter pylori eradication in ulcer patients. Quality of life improves, costs decline].
    MMW Fortschr Med; 2003 Aug; 145(33-34):55. PubMed ID: 14526577
    [No Abstract]   [Full Text] [Related]  

  • 57. The cost-effectiveness of sequential versus standard triple therapy for
    AlRuthia Y; Almadi MA; Alqahtani S; Alrasheed H; Al-Owairdhi M; Alsohaibani F
    Saudi J Gastroenterol; 2021; 27(4):217-222. PubMed ID: 34259193
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of the efficacy and tolerability of four different therapeutic regimens for the Helicobacter pylori eradication.
    Tursi A; Cammarota G; Montalto M; Papa A; Cuoco L; Veneto GM; Cannizzaro O; Fedeli G; Gasbarrini G
    Panminerva Med; 1996 Sep; 38(3):145-9. PubMed ID: 9009677
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardio-cerebrovascular disease and Helicobacter pylori-related metabolic syndrome: We consider eradication therapy as a potential cardio-cerebrovascular prevention strategy.
    Kountouras J; Polyzos SA; Katsinelos P; Zeglinas C; Artemaki F; Tzivras D; Vardaka E; Gavalas E; Romiopoulos I; Simeonidou C; Grigoriadis N; Kountouras C; Dardiotis E; Deretzi G
    Int J Cardiol; 2017 Feb; 229():17-18. PubMed ID: 27887801
    [No Abstract]   [Full Text] [Related]  

  • 60. [Eradication efficiency and Helicobacter pylori resistance to antibiotics in anticipation of IV TH Maastricht consensus issues publication. Editorial].
    Lazebnik LB; Bordin DS; Mikheeva OM; Belousova NL
    Eksp Klin Gastroenterol; 2011; (8):3-7. PubMed ID: 22629748
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.